The live program is aimed at improving the treatment of patients with CLL/SLL through the integration of current NCCN guideline recommendations, clinical evidence that supports the use of novel targeted and cellular therapies, and sequencing strategies. Knowledge from this educational program will enhance HCP s ability to select, sequence, and personalize treatment regimens in alignment with expert consensus guidelines, recent trial data, and patient preferences. HCPs will learn how to integrate newer data into practice in a timely manner and apply shared decision-making strategies in patient care.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
CME included with membership
| Free CME Activity | Free |
| Paid Activity (e.g. Breast/Lung Cancer Congress recordings) | $50 |
| Paid Activity (e.g. Hematologic Malignancies Congress recording) | $90 |
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Anatomic & Clinical Pathology
- Colon & Rectal Surgery
- Communication & Shared Decision-Making
- Dermatopathology
- Evidence-Based Medicine & Research
- Gastroenterology
- Gastrointestinal Surgery
- General Surgery
- Geriatric Medicine
- Gynecologic Oncology
- Head & Neck Surgery
- Health Equity & Inclusion
- Hematology
- Hospice & Palliative Medicine
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Nephrology
- Neurology
- Obstetrics & Gynecology
- Pain Medicine
- Pediatric Hematology-Oncology
- Practice Management & Ethics
- Pulmonary Disease
- Radiation Oncology
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Urological Oncology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pain & Palliative
- Pathology & Lab
- Primary care
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Live
- Credit · Up to 1 credit
- MOC · Up to 1 point
- Commercial Support
-
WhenMar 20 – Nov 30, 2026
-
Society of Hematologic Oncology +1 Relapsed/Refractory CLL/SLL Clinical Insights: Navigating Novel Therapy Integration and Sequencing Considerations – Mobile Microlearning
-
Medscape, LLC Elevating CLL Care: Integrating Evidence, Guidelines, and the Patient Perspective
-
Partners for Advancing Clinical Education An Evolving Standard of Care in Chronic Lymphocytic Leukemia: Patient Perspectives and Clinical Insights on Novel Therapeutic Strategies Across the Disease Continuum
-
National Comprehensive Cancer Network Optimizing Patient Care Coordination Between Academic and Community Settings
-
National Comprehensive Cancer Network Optimizing First-Line Therapy for Diffuse Large B-Cell Lymphoma
-
National Comprehensive Cancer Network Evolving Treatment Strategies for Acute Myeloid Leukemia
